Together, these findings provide insight into the molecular basis of respiratory failure associated with SMA pathogenesis and identify ZPR1 and HoxA5 as potential targets that lay a foundation for developing therapeutic strategies to treat respiratory distress in SMA. The gene discussed is HOXA5; the disease is proximal spinal muscular atrophy.